The role of MET in NSCLC and why earlier TKIs and antibodies have been disappointing.

The role of MET in NSCLC and why earlier TKIs and antibodies have been disappointing.

User Photo
lung

5 years
204 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Mark Kris, MD of Memorial Sloan Kettering discusses the role of MET in NSCLC and why earlier TKIs and antibodies have been disappointing.
Up Next Autoplay